Phuc LeHoang

Phuc LeHoang

Auto-generated profile, based on publicly available information

Phuc LeHoang

Ophthalmology Department, Reference Center in Rare Diseases, DHU Sight Restore, Hôpital Pitié Salpêtrière, University Paris VI, Paris, France

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
MSMarc D. De Smet
Marc D. De Smet
STSimon R.J. Taylor
Simon R.J. Taylor
BBBahram Bodaghi
Bahram Bodaghi
EMElisabetta Miserocchi
Elisabetta Miserocchi
PMPhilip I. Murray
Philip I. Murray
SLSue Lightman
Sue Lightman

1 July 2001 in Medicine
Verified
Journal Article
Closed access
BBBahram Bodaghi
Bahram Bodaghi
NCNathalie Cassoux
Nathalie Cassoux
BWBertrand Wechsler
Bertrand Wechsler
DHDaniele Hannouche
Daniele Hannouche
CFChristine Fardeau
Christine Fardeau
PLPhuc Lehoang
Phuc Lehoang

1 July 2007 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
NCNathalie Cassoux
Nathalie Cassoux
AGAlain Giron
Alain Giron
BBBahram Bodaghi
Bahram Bodaghi
TTThi Ha Chau Tran
Thi Ha Chau Tran
SBSylvie Baudet
Sylvie Baudet
HMHe´lE`nE Merle-Be´rAl
He´lE`nE Merle-Be´rAl
Purpose. To determine the value of IL-10 measurement in aqueous humor (AH) for screening in primary intraocular lymphoma (PIOL). methods. One hundred consecutive diagnostic or therapeutic vitrectomies were performed in patients with uveitis. During surgery, 100 μL of both AH and pure vitreous was taken. IL-10 levels were determined with a standard quantitative sandwich enzyme immunoassay technique. Patients were distributed in two groups: 51 patients with proven PIOL, 108 patients with uveitis divided into 74 with uveitis of proven etiology and 34 with idiopathic uveitis. Groups were compared by ANOVA and the Tukey-Kramer test or nonparametric Wilcoxon test. Distributions were compared by using the χ2 test. Segmentation was derived from the ROC curves by choosing a tradeoff between sensitivity and specificity. results. In patients with PIOL, IL-10 mean values were 2205.5 pg/mL (median: 1467 pg/mL) in the vitreous and 543.4 pg/mL (median: 424 pg/mL) in AH. In patients with uveitis (idiopathic and diagnostic uveitis), mean values were 26.6 pg/mL (median: 8 pg/mL) in the vitreous, and 21.9 pg/mL (median: 8 pg/mL) in AH. IL-10 mean values were significantly different between patients with PIOL and patients with uveitis (P < 10−3). The areas under the curves were 0.989 and 0.962 for vitreous and AH, respectively. A cutoff of 50 pg/mL in the AH was associated with a sensitivity of 0.89 and a specificity of 0.93. In the vitreous, a cutoff value of 400 pg/mL yielded a specificity of 0.99 and a sensitivity of 0.8. conclusions. Diagnosis of PIOL is often made months or years after the initial onset of ocular symptoms. Cytology remains the gold standard for diagnosis. However, measurement of IL-10 in the AH is a good screening test to reduce diagnostic delays.

1 January 2000 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
NCNathalie Cassoux
Nathalie Cassoux
HMHelene Merle-Beral
Helene Merle-Beral
VLVeronique Leblond
Veronique Leblond
BBBahram Bodaghi
Bahram Bodaghi
DMDan Miléa
Dan Miléa
PLPhuc LeHoang
Phuc LeHoang
PURPOSE: To evaluate the clinical, angiographic, and cytopathologic features of ocular and central nervous system (CNS) lymphoma. PATIENTS AND METHODS: Retrospective study of 44 patients over a 10-...

1 March 2010 in Ophthalmology
Verified
Journal Article
Closed access
NRNarsing A. Rao
Narsing A. Rao
AGAmod Gupta
Amod Gupta
LDLaurie Dustin
Laurie Dustin
SCSoon Phaik Chee
Soon Phaik Chee
AOAnnabelle A. Okada
Annabelle A. Okada
RRRussell W. Read
Russell W. Read

18 October 2006 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
BBBahram Bodaghi
Bahram Bodaghi
GGGael Gendron
Gael Gendron
BWBertrand Wechsler
Bertrand Wechsler
CTCéline Terrada
Céline Terrada
NCNathalie Cassoux
Nathalie Cassoux
JPJean-Charles Piette
Jean-Charles Piette
Aim: Severe uveitis is potentially associated with visual impairment or blindness in young patients. Therapeutic strategies remain controversial. The efficacy of interferon alpha-2a (IFN-α2a) in severe uveitis, refractory to steroids and conventional immunosuppressive agents, was evaluated. Patients and methods: Patients were included after a major relapse of uveitis following corticosteroids and immunosuppressants. IFN-α2a (3 million units three times a week) was administered subcutaneously. Efficacy was assessed by improvement in visual acuity, decrease in vitreous haze, resolution of retinal vasculitis and macular oedema, assessed by fundus examination and fluorescein angiography, and decrease in oral prednisone threshold. Results: 45 patients were included. Median age was 32.3 years (range 8–58) and sex ratio (F/M) was 0.66. Uveitis was associated with Behçet’s disease in 23 cases (51.1%) and with other entities in 22 cases (48.9%). Median duration of uveitis before interferon therapy was 34.9 months (range 3.4–168.7) and an average of 3.26 relapses following corticosteroids and immunosuppressants was noted. Uveitis was controlled in 82.6% of patients with Behçet’s disease and 59% of patients with other types of uveitis (p = 0.07). During a mean follow-up of 29.6 months (range 14–55), median oral prednisone threshold decreased significantly from 23.6 mg/day (range 16–45) to 10 mg/d (range 4–14) (p<0.001). Interferon was discontinued in 10 patients (22.2%) with Behçet’s disease and in four patients without Behçet’s disease. Relapses occurred in four and one cases, respectively. Conclusions: Interferon therapy appears to be an efficient strategy in severe and relapsing forms of Behçet’s disease but also in other uveitic entities. However, it seems to act more to suspend rather than cure the disease. Therefore, IFN-α2a may be proposed as a secondline strategy after failure of conventional immunosuppressants.